PM360

OCTOBER 22, 2024

In the pharmaceutical industry, patient support programs (PSPs) and brand teams often work in silos, despite their shared goal of helping patients achieve a certain health outcome. Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs).

Patients 59

Patients Healthcare Provider Pharma Prescription 59

European Pharmaceutical Review

MAY 23, 2024

1 Particularly, CAR-T cell therapy, which uses a patient’s T-cells to fight cancer by altering them so they can find and destroy cancer cells, has emerged as a valuable option for many patients. 2 With this new indication, more patients will be able to access this innovative treatment.

Food and Drug Administration 110

Food and Drug Administration Food Medical Medicine 110

European Pharmaceutical Review

JUNE 12, 2024

Since 2018, biotech company Mikrobiomik has been researching, development and producing innovative biological medicines based on the human microbiome. The study included 92 adult patients with confirmed CDI. After treatment, patients were followed up at intervals of 72 hours, three weeks, eight weeks, three months and six months.

Safety 111

Safety Patients Side effects Healthcare 111

pharmaphorum

SEPTEMBER 22, 2022

California biotech Calibr and partner AbbVie have reported the first clinical data on a new CAR-T technology, which uses “switchable” cells that aim to eliminate the life-threatening side-effects that can occur with this type of immunotherapy. In the absence of the antibody, the CAR-T cells are dormant.

Side effects 52

Side effects Engineering Patients Manufacturing 52

European Pharmaceutical Review

OCTOBER 19, 2023

The development of novel radiotherapeutics ushered in a new era in targeted treatment 1 for cancer, with two separate radiotherapeutic approvals in Europe and the US, in 2018 and 2022. These diagnostics are also paired with therapeutics and act as an imaging biomarker to identify patients who may benefit from the paired therapies.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Side effects Doctors 105

PM360

AUGUST 9, 2022

Medication non-adherence has a staggering impact on the industry’s ability to serve patient well-being and achieve growth. 1 It is by far the leading contributor to preventable healthcare costs in the United States, generating $300–528.4 A patient is diagnosed and prescribed a treatment to correct or mitigate a condition.

Education 59

Education Side effects Physicians Patients 59

European Pharmaceutical Review

AUGUST 14, 2023

The company’s lead candidate, C21, is an angiotensin II type 2 receptor agonist (ATRAG). This data, together with a favourable safety profile, make C21 a potential game-changer for IPF patients, particularly those who are currently not treated due to the side effects of the available drugs, according to Dalsgaard.

Pharma 98

Pharma Side effects Patients Manufacturing 98

European Pharmaceutical Review

AUGUST 15, 2024

1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. for all-comers; HR=0.52

Safety 52

Safety Patients Medical Medicine 52

pharmaphorum

JULY 13, 2022

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment. 2018: @VerveTx founded with concept of one-time Rx to lower LDL as low as possible for as long as possible. . Today: we are announcing.

Side effects 98

Side effects Medicine Patients Marketing 98

Pharmaceutical Technology

NOVEMBER 1, 2022

Israel, another leading adopter, has a thriving EHR technology industry that is adapting to the country’s widespread use of Big Data from its country’s healthcare systems. intervention) was the “cause” of an effect. These studies are often done to understand the side effects of different therapies.

Electronics 111

Electronics Prescription Healthcare Healthcare 111

Pharmaceutical Technology

JANUARY 22, 2023

In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases. The NSAA measures functional motor abilities in DMD patients.

FDA 126

FDA Safety Patients Pharmaceutical 126

Pharmaceutical Technology

NOVEMBER 30, 2022

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

MARCH 24, 2023

New Developments for TB In a recent Phase I clinical trial (NCT03722472), researchers have been able to test the first thermostable TB vaccine in patients. In this trial, patients were given a thermostable version of the vaccine or a non-thermostable vaccine in two treatment regimens.

Pharma 64

Pharma Side effects Marketing Biopharma 64